News related to the ongoing COVID-19 pandemic with focus on the Nordic life science industry.
Updated on a regular basis.
Two ongoing research studies funded by NordForsk are providing new knowledge about COVID-19 related to pregnancy and mental health. The Nordic countries have similar welfare systems, access to high-quality health
Bavarian Nordic has provided an update on the Phase 3 development of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 booster vaccine candidate. The upcoming Phase 3 trial has been redesigned to include
New research from Karolinska Institutet shows that a booster shot of mRNA vaccine to individuals who have received two doses of inactivated vaccine offers the same level of protection against
Several months after COVID-19, one is still at an increased risk of blood clot and bleeding, shows research from Umeå University. The researchers analyzed all COVID-19 cases in Sweden from the
Residential exposure to ambient air pollutants is linked to an elevated risk of SARS-CoV-2 infection, an observational study of young adults in Stockholm, Sweden shows. The study was conducted by
Professor Trine Hyrup Mogensen from Aarhus University will study why some people suffer from serious COVID-19 infections, while others do not become ill at all, even when exposed to massive
Researchers at Karolinska Institutet have developed a new strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants. The approach led to the discovery of multiple nanobodies that
KeyPlants has shipped a first-of-its-kind vaccine manufacturing filling facility to Senegal in West Africa. After the facility is installed and becomes fully operational later in 2022, it will be the
AstraZeneca’s Evusheld, a long-acting antibody combination, has been granted marketing authorization in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and
AstraZeneca’s Evusheld, a long-acting antibody combination, has been recommended for marketing authorization in the EU for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents
Researchers have developed a nasal spray to protect vulnerable people from not only COVID-19 but also from infection with several other viruses. The new treatment formulation that is being tested
The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have announced an initial commitment of up to 90 million USD of coordinated funding toward Pandemic Antiviral
Johan von Schreeb, Professor of global disaster medicine and Head of the Centre for Research on Health Care in Disasters at Karolinska Institutet, has been named Director of Karolinska Institutet’s
An international team of scientist led by researchers from Karolinska Institutet shows that natural killer (NK) cells respond to a certain peptide on the surface of infected cells. The study,
The female sex hormone oestrogen may have protective effect against becoming seriously ill and dying in COVID-19, according to a Umeå University study. “The results are interesting enough to warrant
Vicore Pharma has announced data from an interim analysis suggesting that C21 stabilizes disease and increases lung function in idiopathic pulmonary fibrosis (IPF) patients as quantified by standard FVC (Forced
